Revenio Group Corporation’s Board Members

Image
Pekka Rönkä
Pekka Rönkä, M.Sc. E.E. (b. 1952)
Chair of the Board

Pekka Rönkä has previously acted as Chair of the Board of Directors of HLD Healthy Life Devices Oy and Magnasense Technologies Oy and as member of the Board of Directors of Lifeassays AB. His previous positions include Vice President and General Manager in Thermo Fisher Scientific (1999-2012). In the past, Rönkä has held management positions at Labsystems Oy and served as Managing Directors of Fluilogic Systems Oy and Konelab Oy. Mr. Rönkä has been a member of Revenio’s Board of Directors since March 20, 2014. He is a member of the Audit Committee.

On Dec 31, 2020, Pekka Rönkä and his controlling interest company owned a total of 4,664 Revenio Group Corporation shares and 0 options.

Image
Kyösti Kakkonen
Commercial Counsellor, Kyösti Kakkonen, LL.B. (b. 1956)
Managing Director, Joensuun Kauppa ja Kone Oy, K2 Invest Oy and Kakkonen-Yhtiöt Oy

Kyösti Kakkonen is the founder of Tokmanni Group and served as CEO of the Group for 20 years until 2009. Currently, Mr. Kakkonen acts as CEO, Chair of the Board or member of the Board in several companies of his own, including Joensuun Kauppa ja Kone Oy, K2 Invest Oy, and Kakkonen-Yhtiöt Oy. Mr. Kakkonen has been a member of Revenio's Board of Directors since March 20, 2014.

On Dec 31, 2020, Kyösti Kakkonen and his controlling interest company owned a total of 6,179 Revenio Group Corporation shares and 0 options.

Image
Ann Christine Sundell
Ann-Christine Sundell, MA (b. 1964)
Professional Board member

Ann-Christine Sundell is a member of the Board of Directors of Immunovia Ab, Biocartis Group NV and Förlags Sydvästkusten, Chair of the Board of Directors of Medix Biochemica Group Oy and Deputy Chair of the Board of Raisio Oyj. Ann-Christine Sundell is also a member of the Remuneration Committee of Biocartis Group NV, Chair of the Remuneration Committee of Immunovia Ab, and Chair of the Audit Committee of Raisio Oyj. She has previously held positions as President, Segment Manager, and Sales and Marketing Manager at PerkinElmer (1999–2010). Ms. Sundell has been a member of Revenio’s Board of Directors since March 15, 2016. She is the Chair of Nomination and Remuneration Committee and a member of the Audit Committee.

On Dec 31, 2020, Ann-Christine Sundell and her controlling interest company owned a total of 4,669 Revenio Group Corporation shares and 0 options.

Image
Pekka Tammela
Pekka Tammela, M.Sc. (Econ.) (b. 1962)

Pekka Tammela is a partner in PJ Maa Partners Oy. He has previously served in various managerial positions, such as CFO of Solteq Oyj and Panostaja Oyj, and as an Authorized Public Accountant at PricewaterhouseCoopers and KPMG. He also serves on other Boards of Directors, including SNT-Group Oy, and as Chair of the Board of Normiopaste Oy and Member of the Board of Pikespo Invest Oy Ltd and Trimaster Oy. Mr. Tammela has been a member of Revenio’s Board of Directors since April 3, 2007. He is the Chair of the Audit Committee.

On Dec 31, 2020, Pekka Tammela and his controlling interest company owned a total of 40,774 Revenio Group Corporation shares and 0 options. 

 

Image
Arne Boye Nielsen
Arne Boye Nielsen, MBA (b. 1968)
Member of the Management Group, Demant A/S

Arne Boye Nielsen is a member of the Management Group of Demant A/S. Since 1996 he has served in various managerial positions at Demant A/S, such as President, Communications Business Area and President, Diagnostics Business Area. Nielsen is a Member of the Board of Directors of Össur hf. Nielsen has been a member of Revenio's Board of Directors since June 8, 2020. He is a member of the Nomination and Remuneration Committee. 

On Dec 31, 2020, Arne Boye Nielsen and his controlling interest company owned a total of 293 Revenio Group Corporation shares and 0 options. 

Image
Bill Östman
Bill Östman, M.Sc.E. (b. 1958)
Vice President and General Manager, Thermo Fisher Scientific

Bill Östman works as Vice President & General Manager within the Clinical Diagnostics Division at Thermo Fisher Scientific. He has previously served in various managerial positions at Thermo Fisher Scientific, including Vice President, Sales and Marketing and Chairman of the Board, Managing Director and Site Leader for the company's Finnish entity. Before joining Thermo Fisher, he also held managerial positions at Konelab Oy and KONE Instruments Oy. Östman has been a member of Revenio's Board of Directors since June 8, 2020. He is a member of the Nomination and Remuneration Committee. 

On Dec 31, 2020, Bill Östman and his controlling interest company owned a total of 1,493 Revenio Group Corporation shares and 0 options. 

 

 

 

 

All Board members are independent of the Company and its major shareholders. 

The Board reviews the neutrality of its members on a regular basis. Board members are obligated to provide the Board of Directors with the information required for the assessment of neutrality.